Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,1 USD | +3,68% | -4,02% | -3,73% |
Omzet 2024 * | 12,32 mln. 11,52 mln. | Omzet 2025 * | 48,56 mln. 45,42 mln. | Marktkapitalisatie | 220 mln. 205 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -51 mln. -47,7 mln. | Nettowinst (verlies) 2025 * | -19 mln. -17,77 mln. | EV/omzet 2024 * | 17,8 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,52 x |
K/w-verhouding 2024 * |
-4,45
x | K/w-verhouding 2025 * |
-13,1
x | Werknemers | 40 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,89% |
Recentste transcriptie over Ovid Therapeutics Inc.
1 dag | +3,68% | ||
1 week | -4,02% | ||
Lopende maand | +1,64% | ||
1 maand | +3,33% | ||
3 maanden | -16,67% | ||
6 maanden | -9,62% | ||
Lopend jaar | -3,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01-04-14 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 01-01-19 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 28-06-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 14-06-17 |
Bart Friedman
BRD | Director/Board Member | 79 | 23-11-15 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01-04-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 3,1 | +3,68% | 80 519 |
25-04-24 | 2,99 | -5,08% | 112 117 |
24-04-24 | 3,15 | -1,56% | 113 127 |
23-04-24 | 3,2 | +1,59% | 110 579 |
22-04-24 | 3,15 | -2,48% | 205 940 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,73% | 212 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |